Baumal Caroline 4

What Happened Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals (APLS), disposed of 2,797 shares on January 22, 2026 at $21.77 per share, generating proceeds of $60,878. The transaction is a sale (S) reported as an open market or private sale and was disclosed on a Form 4 filed January 23, 2026.

Key Details

• Transaction date and price: 2026-01-22 at $21.77 per share (2,797 shares; $60,878 total).
• Shares owned after transaction: Not reported in the provided filing.
• Footnote: Sale was to cover tax withholding on Restricted Stock Units released on January 21, 2026 (F1).
• Filing timeliness: Form 4 filed on 2026-01-23 (timely within reporting window).
• Transaction code: S (Sale); method listed as open market or private sale.

Context This sale was executed to satisfy tax withholding associated with RSU vesting and is a routine administrative transaction rather than a directional investment signal. For retail investors, purchases or large, discretionary insider buys typically provide clearer insight into insider sentiment than routine withholding sales.